FIELD: medicine. SUBSTANCE: method involves saturating blood with digoxin in accelerated way during 2-4 h. Hemodynamic parameters are continuously controlled. Stroke and minute volumes are recorded from the beginning of digoxin administration. The dose previous to one causing minute volume reduction is considered to be the optimum saturation dose. EFFECT: enabled positive clinical effect during the first hours of treatment. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING OPTIMAL HEART RATE IN PATIENTS AT ATRIAL FIBRILLATION | 2006 |
|
RU2322192C1 |
| METHOD OF TREATMENT OF PATIENTS WITH LUNG EDEMA | 1995 |
|
RU2116799C1 |
| METHOD FOR PREDICTING ARHYTHMOGENIC ACTION OF CARDIAC GLYCOSIDES | 2000 |
|
RU2226068C2 |
| METHOD OF TREATING ACUTE LEFT VENTRICULAR INSUFFICIENCY OF I-III CLASS IN PATIENTS WITH DIABETES MELLITUS | 2009 |
|
RU2423115C2 |
| METHOD OF HEMODYNAMIC CORRECTION IN NEWBORNS AFTER HYPOXIA | 1992 |
|
RU2067454C1 |
| METHOD OF DETERMINING FUNCTIONAL STATE OF CARDIOVASCULAR SYSTEM | 0 |
|
SU1161079A1 |
| METHOD OF EARLY STAGES OF ATHEROSCLEROSIS DIAGNOSTICS | 2007 |
|
RU2350273C2 |
| METHOD FOR TREATING RESPIRATORY DISTRESS SYNDROME | 1997 |
|
RU2148980C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE POSSESSING HYPOTENSIVE ACTIVITY | 1979 |
|
SU797219A1 |
| METHOD FOR PROTECTING CARDIOVASCULAR SYSTEM DURING OPERATION DEALING WITH MYOCARDIAL REVASCULARIZATION UPON WORKING HEART | 2001 |
|
RU2200552C1 |
